AUGMEDIX INC (AUGX)

Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.

Which stocks are experiencing notable movement on Tuesday?

Which stocks are moving on Tuesday?

Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.

Tuesday's session: gap up and gap down stocks

Let's delve into the US markets on Tuesday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.

Why Is Augmedix (AUGX) Stock Down 41% Today?

Augmedix stock is down on Tuesday as investors in AUGX shares are unimpressed with the company's updated revenue outlook for 2024!

Get insights into the top gainers and losers of Tuesday's pre-market session.

As we await the opening of the US market on Tuesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Pre-market stock movers are worth diving into as we check out all of the hottest news affecting shares on Tuesday morning!

AUGX Stock Earnings: Augmedix Beats EPS, Beats Revenue for Q1 2024

AUGX stock results show that Augmedix beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

AUGX Stock Earnings: Augmedix Beats EPS, Beats Revenue for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Augmedix (NASDAQ:AUGX) just reported results for the first quarter of 2024.Augm...

Which stocks are moving after the closing bell on Monday?

As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.

Augmedix Delivers 40% Revenue Growth for First Quarter of 2024

SAN FRANCISCO, May 13, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today reported...

Augmedix to Participate in Upcoming Investor Conferences in May and June 2024

SAN FRANCISCO, May 03, 2024 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today...

Augmedix Launches Industry’s First Fully-Automated, GenAI-Powered, Medical Documentation Product for Emergency Departments

Following incubation with HCA Healthcare EDs, Augmedix announces the general availability of Augmedix Go in emergency departments...

3 Penny Stocks That Could Make a Big Comeback by the End of Q2

Although penny stocks to rebound represent one of the riskiest market categories, there could be some substance here.

Augmedix Integrates with Andor Health to Revolutionize Ambient Clinical Documentation for Ambulatory Virtual Care

SAN FRANCISCO and ORLANDO, Fla., April 09, 2024 (GLOBE NEWSWIRE) -- In a significant move to streamline healthcare workflows and allow clinicians to...

Augmedix and SADA Forge Partnership to Scale Ambient Documentation and Structured Data Products to Health Systems Nationwide

The partnership enables Augmedix to accelerate scaling efforts for digital health solutions and integrations that work seamlessly at the point of care...

AUGX Stock Earnings: Augmedix Beats EPS, Beats Revenue for Q4 2023

AUGX stock results show that Augmedix beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.

AUGX Stock Earnings: Augmedix Beats EPS, Beats Revenue for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Augmedix (NASDAQ:AUGX) just reported results for the fourth quarter of 2023.Aug...

Augmedix Delivers 45% Revenue Growth and Expanded Gross Margins for Fourth Quarter of 2023

SAN FRANCISCO, March 18, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today...

Augmedix Announces New Positive Data and Enhancements to Its Ambient AI Product, Augmedix Go

New Data Shows Clinicians Save Up to 1 Hour or More per Day Using Augmedix Go

Augmedix to Announce Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024

SAN FRANCISCO, March 08, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient...

Augmedix to Participate in Citizens JMP Technology Conference

SAN FRANCISCO, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading ambient medical documentation and data solutions, today announced that members of its management team will participate in a fireside chat and host investor meetings at the Citizens JMP Technology Conference taking place in San Francisco on March 4, 2024.

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Augmedix, Inc. (NASDAQ: AUGX)

/PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Augmedix, Inc. (NASDAQ: AUGX) on behalf of the company's shareholders. The...

Augmedix Names Tomer Levy as New Senior Vice President of Engineering

With deep experience in developing operational efficiency and innovation, Levy will be working to aid Augmedix in scaling its products, accelerating...

Oversold Conditions For Augmedix (AUGX)

Augmedix Announces Participation in Maxim Group Virtual Healthcare IT Investor Conference

SAN FRANCISCO, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading ambient...

Bag This Bargain Even Cheaper Than CHIEF FINANCIAL OFFICER Ginocchio Did

Augmedix says Q4 revenue is expected to be about $12.5M (NASDAQ:AUGX)

Augmedix (AUGX) exceeds revenue guidance, expecting $12.5M in Q4 2023 and $44.7M for the full year, with a 46% increase in Annual Recurring Revenue.

Augmedix Exits Calendar 2023 with Expected $51 Million in Annual Recurring Revenue

Company Also Expects Fourth Quarter 2023 Revenue Above Guidance, Announces General Availability of Augmedix Go...

7 Micro-Cap Stocks for Risk-Tolerant Investors to Buy in 2024

Micro-cap stocks can be fantastic growth vehicles for your portfolio, providing that you're willing to withstand some volatility.